In vitro and in vivo evaluation of 2-aminoalkanol and 1,2-alkanediamine derivatives against Strongyloides venezuelensis
Background: Strongyloidiasis is a parasitic disease widely present in tropical and subtropical areas. Strongyloides stercoralis represents the main species that infects human beings. Ivermectin is the current drug of choice; however, issues related with treatment failure in patients with diabetes or...
- Autores:
-
Legarda-Ceballos A.L.
López-Abán J.
Del Olmo E.
Escarcena R.
Bustos L.A.
Rojas Caraballo, Jose Vicente
Vicente B.
Fernández-Soto P.
San Feliciano A.
Muro A.
- Tipo de recurso:
- Article of journal
- Fecha de publicación:
- 2016
- Institución:
- Universidad Cooperativa de Colombia
- Repositorio:
- Repositorio UCC
- Idioma:
- OAI Identifier:
- oai:repository.ucc.edu.co:20.500.12494/41843
- Acceso en línea:
- https://doi.org/10.16967/rpe.v4n2a3
http://revia.areandina.edu.co/ojs/index.php/IA/article/view/646
https://hdl.handle.net/20.500.12494/41843
- Palabra clave:
- 1,2 alkanediamine derivative
2 aminoalkanol
antinematodal agent
edelfosine
ivermectin
unclassified drug
[2 (butylamino)hexadecan 1 ol]
[2 (ethylamino)hexadecan 1 ol]
[tert butyl n (1 aminododecan 2 yl)carbamate]
[tert butyl n (1 aminohexadecan 2 yl)carbamate]
aminoalcohol
anthelmintic agent
diamine
animal cell
animal experiment
animal model
animal tissue
Article
controlled study
cytotoxicity test
drug efficacy
drug identification
drug screening
drug structure
feces analysis
female
in vitro study
in vivo study
LC50
male
mouse
nonhuman
outcome assessment
rat
Strongyloides venezuelensis
strongyloidiasis
structure activity relation
XTT assay
animal
chemical structure
chemistry
drug effects
parasitology
Strongyloides
Amino Alcohols
Animals
Anthelmintics
Diamines
Male
Mice
Molecular Structure
Rats
Strongyloides
Strongyloidiasis
Structure-Activity Relationship
- Rights
- closedAccess
- License
- http://purl.org/coar/access_right/c_14cb
id |
COOPER2_baee5bc9aa91754a0c5595a9ce44adcc |
---|---|
oai_identifier_str |
oai:repository.ucc.edu.co:20.500.12494/41843 |
network_acronym_str |
COOPER2 |
network_name_str |
Repositorio UCC |
repository_id_str |
|
dc.title.spa.fl_str_mv |
In vitro and in vivo evaluation of 2-aminoalkanol and 1,2-alkanediamine derivatives against Strongyloides venezuelensis |
title |
In vitro and in vivo evaluation of 2-aminoalkanol and 1,2-alkanediamine derivatives against Strongyloides venezuelensis |
spellingShingle |
In vitro and in vivo evaluation of 2-aminoalkanol and 1,2-alkanediamine derivatives against Strongyloides venezuelensis 1,2 alkanediamine derivative 2 aminoalkanol antinematodal agent edelfosine ivermectin unclassified drug [2 (butylamino)hexadecan 1 ol] [2 (ethylamino)hexadecan 1 ol] [tert butyl n (1 aminododecan 2 yl)carbamate] [tert butyl n (1 aminohexadecan 2 yl)carbamate] aminoalcohol anthelmintic agent diamine animal cell animal experiment animal model animal tissue Article controlled study cytotoxicity test drug efficacy drug identification drug screening drug structure feces analysis female in vitro study in vivo study LC50 male mouse nonhuman outcome assessment rat Strongyloides venezuelensis strongyloidiasis structure activity relation XTT assay animal chemical structure chemistry drug effects parasitology Strongyloides Amino Alcohols Animals Anthelmintics Diamines Male Mice Molecular Structure Rats Strongyloides Strongyloidiasis Structure-Activity Relationship |
title_short |
In vitro and in vivo evaluation of 2-aminoalkanol and 1,2-alkanediamine derivatives against Strongyloides venezuelensis |
title_full |
In vitro and in vivo evaluation of 2-aminoalkanol and 1,2-alkanediamine derivatives against Strongyloides venezuelensis |
title_fullStr |
In vitro and in vivo evaluation of 2-aminoalkanol and 1,2-alkanediamine derivatives against Strongyloides venezuelensis |
title_full_unstemmed |
In vitro and in vivo evaluation of 2-aminoalkanol and 1,2-alkanediamine derivatives against Strongyloides venezuelensis |
title_sort |
In vitro and in vivo evaluation of 2-aminoalkanol and 1,2-alkanediamine derivatives against Strongyloides venezuelensis |
dc.creator.fl_str_mv |
Legarda-Ceballos A.L. López-Abán J. Del Olmo E. Escarcena R. Bustos L.A. Rojas Caraballo, Jose Vicente Vicente B. Fernández-Soto P. San Feliciano A. Muro A. |
dc.contributor.author.none.fl_str_mv |
Legarda-Ceballos A.L. López-Abán J. Del Olmo E. Escarcena R. Bustos L.A. Rojas Caraballo, Jose Vicente Vicente B. Fernández-Soto P. San Feliciano A. Muro A. |
dc.subject.spa.fl_str_mv |
1,2 alkanediamine derivative 2 aminoalkanol antinematodal agent edelfosine ivermectin unclassified drug [2 (butylamino)hexadecan 1 ol] [2 (ethylamino)hexadecan 1 ol] [tert butyl n (1 aminododecan 2 yl)carbamate] [tert butyl n (1 aminohexadecan 2 yl)carbamate] aminoalcohol anthelmintic agent diamine animal cell animal experiment animal model animal tissue Article controlled study cytotoxicity test drug efficacy drug identification drug screening drug structure feces analysis female in vitro study in vivo study LC50 male mouse nonhuman outcome assessment rat Strongyloides venezuelensis strongyloidiasis structure activity relation XTT assay animal chemical structure chemistry drug effects parasitology Strongyloides Amino Alcohols Animals Anthelmintics Diamines Male Mice Molecular Structure Rats Strongyloides Strongyloidiasis Structure-Activity Relationship |
topic |
1,2 alkanediamine derivative 2 aminoalkanol antinematodal agent edelfosine ivermectin unclassified drug [2 (butylamino)hexadecan 1 ol] [2 (ethylamino)hexadecan 1 ol] [tert butyl n (1 aminododecan 2 yl)carbamate] [tert butyl n (1 aminohexadecan 2 yl)carbamate] aminoalcohol anthelmintic agent diamine animal cell animal experiment animal model animal tissue Article controlled study cytotoxicity test drug efficacy drug identification drug screening drug structure feces analysis female in vitro study in vivo study LC50 male mouse nonhuman outcome assessment rat Strongyloides venezuelensis strongyloidiasis structure activity relation XTT assay animal chemical structure chemistry drug effects parasitology Strongyloides Amino Alcohols Animals Anthelmintics Diamines Male Mice Molecular Structure Rats Strongyloides Strongyloidiasis Structure-Activity Relationship |
description |
Background: Strongyloidiasis is a parasitic disease widely present in tropical and subtropical areas. Strongyloides stercoralis represents the main species that infects human beings. Ivermectin is the current drug of choice; however, issues related with treatment failure in patients with diabetes or infected with T-lymphotropic virus-1 make the identification of new molecules for alternative treatment a priority. In the present study, the activity of sphingosine-related aminoalcohol and diamine were evaluated against Strongyloides venezuelensis third-stage larva (L3) cultures and experimental infections in mice. Methods: The efficacy of each compound against L3 was assessed using both XTT (2,3-bis-(2-methoxy-4-nitro-5-sulfophenyl)-2H-tetrazolium-5-carboxanilide) assay and microscopic observation with concentrations ranging from 1 to 350 µM. Cytotoxicity was evaluated using J774.2 macrophage cell line and XTT assay. Lethal concentration 50 (LC50), selectivity index (SI) and structure-activity relationships were established. The activity compounds 4 (2-(ethylamino) hexadecan-1-ol), 6 (2-(butylamino) hexadecan-1-ol), 17 (tert-butyl N-(1-aminododecan-2-yl) carbamate) and 18 (tert-butyl N-(1-aminohexadecan-2-yl) carbamate) were further assessed against experimental S. venezuelensis infections in CD1 mice measuring reductions in the numbers of parthenogenetic females and egg passed in faeces. Mice were infected with 3,000 L3 and treated with 20 mg/kg/day for five days. Results: In the screening study of 15 aminoalcohols [lauryl (n = 9); palmityl (n = 13); stearyl (n = 15) and alcohol derivatives], the presence of a palmitol chain was associated with the highest efficacy against L3 (LC50 31.9-39.1 µM). Alkylation of the 2-amino group with medium size fragments as ethyl or n-butyl showed the best larvicidal activity. The dialkylation did not improve efficacy. Aminoalcohols 4 and 6 showed the highest SI (1.5 and 1.6, respectively). With respect to diamine derivative compounds, a chain size of sixteen carbon atoms (palmitoyl chain, n = 13), and the alkylation of the 2-amino group with medium-sized fragments, were associated with the highest lethal activities. The presence of carbamoyl group in diamines 17 and 18 yielded high SI (1.7 and 1.4, respectively). Infected mice treated with aminoalcohol 6 showed reduction in parthenogenetic females (59 %) and eggs in faeces (51 %). Conclusions: These results support the potentiality of aminoalcohol and diamine sphingosine-related compounds as suitable prototypes for developing new promising drugs against strongyloidiasis. © 2016 The Author(s). |
publishDate |
2016 |
dc.date.issued.none.fl_str_mv |
2016 |
dc.date.accessioned.none.fl_str_mv |
2021-12-16T22:15:50Z |
dc.date.available.none.fl_str_mv |
2021-12-16T22:15:50Z |
dc.type.none.fl_str_mv |
Artículo |
dc.type.coar.fl_str_mv |
http://purl.org/coar/resource_type/c_2df8fbb1 |
dc.type.coar.none.fl_str_mv |
http://purl.org/coar/resource_type/c_6501 |
dc.type.coarversion.none.fl_str_mv |
http://purl.org/coar/version/c_970fb48d4fbd8a85 |
dc.type.driver.none.fl_str_mv |
info:eu-repo/semantics/article |
dc.type.redcol.none.fl_str_mv |
http://purl.org/redcol/resource_type/ART |
dc.type.version.none.fl_str_mv |
info:eu-repo/semantics/publishedVersion |
format |
http://purl.org/coar/resource_type/c_6501 |
status_str |
publishedVersion |
dc.identifier.none.fl_str_mv |
https://doi.org/10.16967/rpe.v4n2a3 http://revia.areandina.edu.co/ojs/index.php/IA/article/view/646 |
dc.identifier.issn.spa.fl_str_mv |
17563305 |
dc.identifier.uri.none.fl_str_mv |
https://hdl.handle.net/20.500.12494/41843 |
dc.identifier.bibliographicCitation.spa.fl_str_mv |
Legarda AL,López J,Del Olmo E,Escarcena R,Bustos LA,Rojas J,Vicente B,Fernández P,San Feliciano A,Muro A. In vitro and in vivo evaluation of 2-aminoalkanol and 1,2-alkanediamine derivatives against Strongyloides venezuelensis. Parasit Vectors. 2016. 9. (1):p. 364-364. . |
url |
https://doi.org/10.16967/rpe.v4n2a3 http://revia.areandina.edu.co/ojs/index.php/IA/article/view/646 https://hdl.handle.net/20.500.12494/41843 |
identifier_str_mv |
17563305 Legarda AL,López J,Del Olmo E,Escarcena R,Bustos LA,Rojas J,Vicente B,Fernández P,San Feliciano A,Muro A. In vitro and in vivo evaluation of 2-aminoalkanol and 1,2-alkanediamine derivatives against Strongyloides venezuelensis. Parasit Vectors. 2016. 9. (1):p. 364-364. . |
dc.relation.ispartofjournal.spa.fl_str_mv |
PARASITE VECTOR |
dc.rights.accessrights.none.fl_str_mv |
info:eu-repo/semantics/closedAccess |
dc.rights.coar.none.fl_str_mv |
http://purl.org/coar/access_right/c_14cb |
eu_rights_str_mv |
closedAccess |
rights_invalid_str_mv |
http://purl.org/coar/access_right/c_14cb |
dc.format.extent.spa.fl_str_mv |
364-364 |
dc.publisher.spa.fl_str_mv |
BioMed Central Ltd. |
institution |
Universidad Cooperativa de Colombia |
repository.name.fl_str_mv |
Repositorio Institucional Universidad Cooperativa de Colombia |
repository.mail.fl_str_mv |
bdigital@metabiblioteca.com |
_version_ |
1814246747505950720 |
spelling |
Legarda-Ceballos A.L.López-Abán J.Del Olmo E.Escarcena R.Bustos L.A.Rojas Caraballo, Jose VicenteVicente B.Fernández-Soto P.San Feliciano A.Muro A.2021-12-16T22:15:50Z2021-12-16T22:15:50Z2016https://doi.org/10.16967/rpe.v4n2a3http://revia.areandina.edu.co/ojs/index.php/IA/article/view/64617563305https://hdl.handle.net/20.500.12494/41843Legarda AL,López J,Del Olmo E,Escarcena R,Bustos LA,Rojas J,Vicente B,Fernández P,San Feliciano A,Muro A. In vitro and in vivo evaluation of 2-aminoalkanol and 1,2-alkanediamine derivatives against Strongyloides venezuelensis. Parasit Vectors. 2016. 9. (1):p. 364-364. .Background: Strongyloidiasis is a parasitic disease widely present in tropical and subtropical areas. Strongyloides stercoralis represents the main species that infects human beings. Ivermectin is the current drug of choice; however, issues related with treatment failure in patients with diabetes or infected with T-lymphotropic virus-1 make the identification of new molecules for alternative treatment a priority. In the present study, the activity of sphingosine-related aminoalcohol and diamine were evaluated against Strongyloides venezuelensis third-stage larva (L3) cultures and experimental infections in mice. Methods: The efficacy of each compound against L3 was assessed using both XTT (2,3-bis-(2-methoxy-4-nitro-5-sulfophenyl)-2H-tetrazolium-5-carboxanilide) assay and microscopic observation with concentrations ranging from 1 to 350 µM. Cytotoxicity was evaluated using J774.2 macrophage cell line and XTT assay. Lethal concentration 50 (LC50), selectivity index (SI) and structure-activity relationships were established. The activity compounds 4 (2-(ethylamino) hexadecan-1-ol), 6 (2-(butylamino) hexadecan-1-ol), 17 (tert-butyl N-(1-aminododecan-2-yl) carbamate) and 18 (tert-butyl N-(1-aminohexadecan-2-yl) carbamate) were further assessed against experimental S. venezuelensis infections in CD1 mice measuring reductions in the numbers of parthenogenetic females and egg passed in faeces. Mice were infected with 3,000 L3 and treated with 20 mg/kg/day for five days. Results: In the screening study of 15 aminoalcohols [lauryl (n = 9); palmityl (n = 13); stearyl (n = 15) and alcohol derivatives], the presence of a palmitol chain was associated with the highest efficacy against L3 (LC50 31.9-39.1 µM). Alkylation of the 2-amino group with medium size fragments as ethyl or n-butyl showed the best larvicidal activity. The dialkylation did not improve efficacy. Aminoalcohols 4 and 6 showed the highest SI (1.5 and 1.6, respectively). With respect to diamine derivative compounds, a chain size of sixteen carbon atoms (palmitoyl chain, n = 13), and the alkylation of the 2-amino group with medium-sized fragments, were associated with the highest lethal activities. The presence of carbamoyl group in diamines 17 and 18 yielded high SI (1.7 and 1.4, respectively). Infected mice treated with aminoalcohol 6 showed reduction in parthenogenetic females (59 %) and eggs in faeces (51 %). Conclusions: These results support the potentiality of aminoalcohol and diamine sphingosine-related compounds as suitable prototypes for developing new promising drugs against strongyloidiasis. © 2016 The Author(s).josev.rojas@campusucc.edu.co364-364BioMed Central Ltd.1,2 alkanediamine derivative2 aminoalkanolantinematodal agentedelfosineivermectinunclassified drug[2 (butylamino)hexadecan 1 ol][2 (ethylamino)hexadecan 1 ol][tert butyl n (1 aminododecan 2 yl)carbamate][tert butyl n (1 aminohexadecan 2 yl)carbamate]aminoalcoholanthelmintic agentdiamineanimal cellanimal experimentanimal modelanimal tissueArticlecontrolled studycytotoxicity testdrug efficacydrug identificationdrug screeningdrug structurefeces analysisfemalein vitro studyin vivo studyLC50malemousenonhumanoutcome assessmentratStrongyloides venezuelensisstrongyloidiasisstructure activity relationXTT assayanimalchemical structurechemistrydrug effectsparasitologyStrongyloidesAmino AlcoholsAnimalsAnthelminticsDiaminesMaleMiceMolecular StructureRatsStrongyloidesStrongyloidiasisStructure-Activity RelationshipIn vitro and in vivo evaluation of 2-aminoalkanol and 1,2-alkanediamine derivatives against Strongyloides venezuelensisArtículohttp://purl.org/coar/resource_type/c_6501http://purl.org/coar/resource_type/c_2df8fbb1http://purl.org/coar/version/c_970fb48d4fbd8a85info:eu-repo/semantics/articlehttp://purl.org/redcol/resource_type/ARTinfo:eu-repo/semantics/publishedVersionPARASITE VECTORinfo:eu-repo/semantics/closedAccesshttp://purl.org/coar/access_right/c_14cbPublication20.500.12494/41843oai:repository.ucc.edu.co:20.500.12494/418432024-08-20 16:17:20.358metadata.onlyhttps://repository.ucc.edu.coRepositorio Institucional Universidad Cooperativa de Colombiabdigital@metabiblioteca.com |